Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cgh.2021.04.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation.
J Clin Oncol
January 2025
George M. Rodgers, MD, PhD, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; and Jeffrey A. Gilreath, PharmD, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation.
J Clin Oncol
January 2025
Shun Lu, MD, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and Jiong Wu, MD, Cancer Hospital, Fudan University, Shanghai, China.
Queries on Sudden Infant Death Syndrome-Reply.
JAMA Pediatr
January 2025
Department of Epidemiology & Biostatistics, University of California San Francisco.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!